Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Xanthon raises $12mm in private placement

Executive Summary

In a Series D private placement to returning investors Intersouth Partners, Franklin Street Partners, Cordova Technology Partners, the Aurora Funds, Centennial Venture Partners Fund, and the North Carolina Technological Development Authority, and new investor Noro-Mosley Partners, Xanthon (DNA and RNA analysis technology) raised $12mm.
Deal Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register